Physician profile
David Harrison
NPI 1497702302
$457.52
in general payments reported to CMS, 2019-2025
16 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.72 · 2020: $11.78 · 2024: $132 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $428.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $57.56 | 2024 | Voquezna |
| Lilly USA, LLC | $56.66 | 2025 | Zepbound, Mounjaro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.53 | 2024-2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $43.19 | 2025 | |
| Biosense Webster, INC. | $31.99 | 2025 | Carto 3 |
| Allergan, INC. | $29.50 | 2019-2020 | |
| Amgen INC. | $28.45 | 2024-2025 | Otezla, Repatha, Repatha |
| Organogenesis INC. | $22.22 | 2024 | Affinity |
| Biogen, INC. | $20.83 | 2025 | Skyclarys |
| Aimmune Therapeutics, INC. | $20.66 | 2025 | Vowst |
| Astrazeneca Pharmaceuticals Lp | $19.33 | 2025 | Farxiga |
| Mimedx Group, INC. | $16.88 | 2024 | |
| Eisai INC. | $16.83 | 2025 | |
| Exact Sciences Corporation | $15.11 | 2025 | The Cologuard Plus Collection Kit |
| Kowa Pharmaceuticals America, INC. | $14.00 | 2025 | Zoryve |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $13.78 | 2025 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.